Cambium Medical Technologies LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2013-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.cambiumbio.com
Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease
Phase 1
Completed
- Conditions
- Dry EyeGraft-versus-host-diseaseOcular Discomfort
- Interventions
- Biological: Vehicle ControlBiological: CAM-101 10%Biological: CAM-101 30%
- First Posted Date
- 2018-01-30
- Last Posted Date
- 2021-07-27
- Lead Sponsor
- Cambium Medical Technologies LLC
- Target Recruit Count
- 64
- Registration Number
- NCT03414645
- Locations
- 🇺🇸
University of Michigan - Kellogg Clinical Research Center, Ann Arbor, Michigan, United States
🇺🇸Byers Eye Institute of Stanford University, Palo Alto, California, United States
🇺🇸Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath